The Patent Finder

Ardana Bioscience Limited

Also on record
Records under this name other than patents Ardana Bioscience Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Ardana Bioscience Limited

PatentTitleStatus Expires Confidence
US 8,192,719Methods and kits to diagnose growth hormone deficiency by oral administration of EP 1572 or EP 1573 compounds
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,098,305Sustained release of microcrystalline peptide suspensions
Formerly held
Term ended
Term ended Apr 9, 2023 · From the USPTO record
Term endedTerm ended Apr 9, 2023From the USPTO record
US 8,415,300Sustained release of microcrystalline peptide suspensions
Formerly held
Term ended
Ended no later than Feb 19, 2022 · From the USPTO record
Term endedEnded no later than Feb 19, 2022From the USPTO record
US 9,388,216Methods of treating reproductive cancer
Formerly held
Lapsed on the fee record
Ended Jul 12, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jul 12, 2020From the USPTO record
US 7,361,633Screening method and anti-tumor drug candidate obtained therefrom
Formerly held
Lapsed on the fee record
Ended Apr 22, 2020 · From the USPTO record
Lapsed on the fee recordEnded Apr 22, 2020From the USPTO record
US 6,187,323Stable gel mixture in the form of a mixture of oleogel and aqueous gel, process for its preparation, pharmaceutical and cosmetic compositions comprising it, and use of the pharmaceutical compositions
Formerly held
Term ended
Term ended Dec 3, 2018 · From the USPTO record
Term endedTerm ended Dec 3, 2018From the USPTO record
US 7,615,210Treatment of endometriosis
Formerly held
Lapsed on the fee record
Ended Nov 10, 2013 · From the USPTO record
Lapsed on the fee recordEnded Nov 10, 2013From the USPTO record
US 6,124,263Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
Lapsed on the fee record
Ended Sep 26, 2012 · From the USPTO record
Lapsed on the fee recordEnded Sep 26, 2012From the USPTO record
US 6,077,523Process to manufacture implants containing bioactive peptides
Lapsed on the fee record
Ended Jun 20, 2012 · From the USPTO record
Lapsed on the fee recordEnded Jun 20, 2012From the USPTO record
US 6,025,471Diazaspiro, azepino and azabicyclo therapeutic peptides
Lapsed on the fee record
Ended Feb 15, 2012 · From the USPTO record
Lapsed on the fee recordEnded Feb 15, 2012From the USPTO record
10 of 24 patents shown.
Pro members see all 24.
Pro members: see all 24 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited